CompletedPhase 4NCT05439772
Examining the Effect of Ondansetron on Bowel Prep Success
Studying Eosinophilic gastroenteritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- State University of New York - Downstate Medical Center
- Principal Investigator
- Thomas Wallach, MD, L. AcSUNY Downstate HSU
- Intervention
- Ondansetron(drug)
- Enrollment
- 41 enrolled
- Eligibility
- 2-20 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- SUNY Downstate University Hospital of Brooklyn, Brooklyn, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05439772 on ClinicalTrials.govOther trials for Eosinophilic gastroenteritis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07506746PRospective Registry of Esophageal MotilityIRCCS San Raffaele
- ACTIVE NOT RECRUITINGPHASE2NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveRegeneron Pharmaceuticals